טוען...
Brain metastases from renal cell carcinoma in the era of tyrosine kinase inhibitors
BACKGROUND: The effectiveness of tyrosine kinase inhibitors (TKI) in preventing brain metastases in patients with renal cell carcinoma (RCC) is unclear. METHODS: Preclinical studies were conducted to determine the steady-state brain and plasma concentrations of sorafenib and sunitinib in mice defici...
שמור ב:
| הוצא לאור ב: | Clin Genitourin Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4467684/ https://ncbi.nlm.nih.gov/pubmed/23265925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2012.11.001 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|